Associated equity: OSE Immunotherapeutics
OSE Immunotherapeutics (OSE) is based in Nantes and Paris in France and is listed on the Euronext Paris exchange. It is developing immunotherapies for the treatment of solid tumours and autoimmune diseases and has established several partnerships with large pharma companies.
OSE Immunotherapeutics — 9 videos in collection
OSE Immunotherapeutics (PAR:OSE) is based in Nantes and Paris in France and is listed on the Euronext Paris exchange.
There are five key reasons why OSE may be considered an attractive investment.
If you would like to learn more about OSE Immunotherapeutics, please see our latest research here.